N
News Analysis
finance.yahoo.com

finance.yahoo.com ·

Positive

Mckesson Q4 Earnings Call Highlights

PhysicianRegulatoryRetirementsAdviser

All NewsRead the full story on finance.yahoo.com

The full article is on the original publisher site. This page only shows the headline and a very short excerpt.

AI insight

AI-generated

McKesson's strong earnings reflect robust demand in specialty and oncology pharmaceuticals, a high-margin segment. The planned separation of Medical-Surgical Solutions with Apollo investment signals a strategic shift. No direct commodity or supply chain scarcity is indicated; the impact is company-specific and sectoral for healthcare distributors and specialty pharma.

Signals our AI researcher identified

Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.

  • McKesson revenue up 12% to $403B in FY2026
  • Adjusted EPS up 18% to $39.11
  • Specialty/oncology revenue up 35%
  • FY2027 EPS guidance $43.80-$44.60
  • Plans $5B share repurchase and $1.25B Apollo investment in Medical-Surgical Solutions

About the publisher

finance.yahoo.com is one of the en-language news outlets that News Analysis aggregates. Coverage from this source appears in our global feed alongside the publisher's own reporting.

Topic context

finance.yahoo.com files this story under "physician" in the GDELT knowledge graph. News Analysis surfaces coverage based on the same open classification taxonomy.

Mckesson Q4 Earnings Call Highlights — News Analysis